TB-500 Import Supplier — South Korea

Research Use Only: All compounds supplied by Aarise Healthcare are strictly for laboratory research and scientific investigation. Not intended for human consumption, therapeutic use, or clinical application. All purchases must comply with applicable local laws and regulations.

Aarise Healthcare exports TB-500 (CAS: 77591-33-4) to research institutions in South Korea. Our WHO-GMP certified facility in India supplies 98%+ purity TB-500 for wound healing and actin modulation research.

TB-500 Export Specifications for South Korea

Compound	TB-500
CAS Number	77591-33-4
Purity	98%+ (HPLC verified)
Form	Lyophilised powder
Regulatory Reference	MFDS
Shipping	DHL/FedEx temperature-controlled
Transit to South Korea	5-10 business days
Documentation	CoA, HPLC, MS, export docs

Research Applications of TB-500

TB-500 is used in wound healing and actin modulation research. Research institutions in South Korea source this compound for preclinical studies under applicable MFDS research regulations.

Why South Korea Researchers Source TB-500 from India

• WHO-GMP certified Indian manufacturer — internationally recognised compliance
• Competitive pricing for bulk research quantities
• Full export documentation package for MFDS compliance
• Temperature-controlled DHL/FedEx shipping to South Korea
• Dedicated international research supply team
• 98%+ purity guaranteed with independent third-party CoA

Related Peptides in South Korea

Semaglutide in South Korea | Tirzepatide in South Korea | Retatrutide in South Korea | Liraglutide in South Korea

TB-500 — Other Countries

TB-500 in USA | TB-500 in UK | TB-500 in Germany | TB-500 in Australia

Source from India — Key Manufacturing Cities

TB-500 in Mumbai, India | TB-500 in Delhi, India | TB-500 in Hyderabad, India | TB-500 in Bangalore, India

Request TB-500 for your South Korea research facility: Send your institution details and quantity requirements. We respond within 24 hours with FOB pricing and export documentation.